The Effects of Sports Drinks on Urinary Lithogenicity

The Effects of Sports Drinks on Urinary Lithogenicity

Sponsors

Lead sponsor: VA New York Harbor Healthcare System

Source VA New York Harbor Healthcare System
Brief Summary

The effect of sports drinks on the tendency to form kidney stones has not been assessed. Patients will drink 1 liter a day of 2 sports drinks and collect urine to determine changes in urine chemistry that may decrease the risk of forming stones.

Detailed Description

Participants will drink 1 liter of water each day for one week in the control period, then 1 liter of sports drink each day for one week during the experimental period. Urine collections will be performed during both periods. Diet will be chosen by participants and a food diary will be kept so that participants can replicate diet during the urine collections.

Overall Status Completed
Start Date March 2006
Completion Date September 2006
Primary Completion Date March 2006
Phase N/A
Study Type Interventional
Primary Outcome
Measure Time Frame
Urinary supersaturation of calcium oxalate
Urinary citrate excretion
Urinary calcium excretion
Urinary sodium excretion
Enrollment 10
Condition
Intervention

Intervention type: Drug

Intervention name: Gatorade

Intervention type: Drug

Intervention name: Performance

Eligibility

Criteria:

Inclusion Criteria:

- age 18-80 years old

- men and women

- able to sign informed consent

Exclusion Criteria:

- history of kidney stones

- bone disease

- parathyroid disease

Gender: All

Minimum age: 18 Years

Maximum age: 80 Years

Healthy volunteers: Accepts Healthy Volunteers

Overall Official
Last Name Role Affiliation
David S Goldfarb, MD Study Director New York Harbor VAMC
Location
facility New York Harbor VAMC
Location Countries

United States

Verification Date

February 2011

Responsible Party

Name title: David S Goldfarb MD

Organization: New York Harbor VA Medical Center

Keywords
Has Expanded Access No
Condition Browse
Study Design Info

Allocation: Non-Randomized

Intervention model: Crossover Assignment

Primary purpose: Prevention

Masking: None (Open Label)

Source: ClinicalTrials.gov